In addition to their own research and development, drug companies have been adding new products by buying or merging with other companies.
Importantly, these systems have the potential to dramatically impact biomedical applications in the areas of drug development, drug and toxicology screening, disease modeling, and the emerging area of personalized precision medicine.
Plasticity is evident in such diverse phenomena as learning and memory, brain development, drug tolerance, sprouting of axon terminals after a brain lesion, and various cellular forms of activity-dependent synaptic plasticity such as long-term potentiation and long-term depression.
The preparation of liposomes is a routine procedure and the possibility of engineering liposomes of varying size, as well as incorporating different membrane proteins on their surface, has made them useful for many biotechnological applications including vaccine development, drug delivery, and gene delivery.
Experience and demonstrated knowledge of real world data (RWD) and RWE development, drug and/or device development and policy, and/or drug coverage and reimbursement approaches.
These CBOs in cooperation with foreign non-governmental organizations (NGOs) have been working collaboratively over the years to increase capacity through trainings, project development, drug procurement, infrastructure building, and fundraising to support this healthcare system [12].
